Literature DB >> 34022017

A Case Report of Portopulmonary Hypertension Precipitated by Transjugular Intrahepatic Portosystemic Shunt.

Jasmine H Tatah1, E Kenneth Weir1, Kurt W Prins1, Thenappan Thenappan2.   

Abstract

We report here a case of portopulmonary hypertension following transjugular intrahepatic portosystemic shunt.
Copyright © 2020 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abernethy malformation; cirrhosis; portal hypertension; pulmonary arterial hypertension; pulmonary vascular remodeling

Mesh：

Year:  2021        PMID： 34022017      PMCID： PMC8256433          DOI： 10.1016/j.chest.2020.11.014

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  14 in total

1.  Cardiac volume overload and pulmonary hypertension in long-term follow-up of patients with a transjugular intrahepatic portosystemic shunt.

Authors:  A Wannhoff; T Hippchen; C S Weiss; K Friedrich; C Rupp; C Neumann-Haefelin; M Dollinger; C Antoni; U Stampfl; P Schemmer; W Stremmel; K H Weiss; B Radeleff; H A Katus; D N Gotthardt
Journal:  Aliment Pharmacol Ther       Date:  2016-02-26       Impact factor: 8.171

2.  Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.

Authors:  Jayant A Talwalkar; Karen L Swanson; Michael J Krowka; James C Andrews; Patrick S Kamath
Journal:  Gastroenterology       Date:  2011-06-30       Impact factor: 22.682

3.  Portopulmonary hypertension and hepatopulmonary syndrome: a clinician-oriented overview.

Authors:  Mateo Porres-Aguilar; Jose T Altamirano; Aldo Torre-Delgadillo; Michael R Charlton; Andres Duarte-Rojo
Journal:  Eur Respir Rev       Date:  2012-09-01

4.  Transjugular Portosystemic Shunt Reductions: A Retrospective Single-Center Experience.

Authors:  Arthur S Joseph; Barjinder Sandhu; Adam Khalil; Jorge Lopera
Journal:  J Vasc Interv Radiol       Date:  2019-06       Impact factor: 3.464

5.  Pulmonary hypertension associated with cirrhosis of the liver and with portacaval shunts.

Authors:  R M Senior; R C Britton; G M Turino; J A Wood; G A Langer; A P Fishman
Journal:  Circulation       Date:  1968-01       Impact factor: 29.690

6.  A central role for CD68(+) macrophages in hepatopulmonary syndrome. Reversal by macrophage depletion.

Authors:  Thenappan Thenappan; Ankush Goel; Glenn Marsboom; Yong-Hu Fang; Peter T Toth; Hannah J Zhang; Hidemi Kajimoto; Zhigang Hong; Jonathan Paul; Christian Wietholt; Jennifer Pogoriler; Lin Piao; Jalees Rehman; Stephen L Archer
Journal:  Am J Respir Crit Care Med       Date:  2010-12-10       Impact factor: 21.405

7.  Transjugular intrahepatic portosystemic shunt worsens the hyperdynamic circulatory state of the cirrhotic patient: preliminary report of a prospective study.

Authors:  D Azoulay; D Castaing; A Dennison; W Martino; D Eyraud; H Bismuth
Journal:  Hepatology       Date:  1994-01       Impact factor: 17.425

8.  Successful treatment of pulmonary hypertension secondary to congenital extrahepatic portocaval shunts (Abernethy type 2) by living donor liver transplantation after surgical shunt ligation.

Authors:  Taku Iida; Yasuhiro Ogura; Hiraku Doi; Shintaro Yagi; Hiroyuki Kanazawa; Hisashi Imai; Seisuke Sakamoto; Shinya Okamoto; Shinji Uemoto
Journal:  Transpl Int       Date:  2009-09-15       Impact factor: 3.782

9.  Predictors of mortality after transjugular portosystemic shunt.

Authors:  Mona Ascha; Sami Abuqayyas; Ibrahim Hanouneh; Laith Alkukhun; Mark Sands; Raed A Dweik; Adriano R Tonelli
Journal:  World J Hepatol       Date:  2016-04-18

10.  Pulmonary arterial hypertension combined with a high cardiac output state: Three remarkable cases.

Authors:  Onno A Spruijt; Harm-Jan Bogaard; Anton Vonk-Noordegraaf
Journal:  Pulm Circ       Date:  2013-04       Impact factor: 3.017
View more
  1 in total

Review 1.  Synapomorphic features of hepatic and pulmonary vasculatures include comparable purinergic signaling responses in host defense and modulation of inflammation.

Authors:  Dusan Hanidziar; Simon C Robson
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-06-09       Impact factor: 4.871
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.